Small vessel disease: mechanisms and clinical implications
Small vessel disease is a disorder of cerebral microvessels that causes white matter hyperintensities and several other common abnormalities (eg, recent small subcortical infarcts and lacunes) seen on brain imaging. Despite being a common cause of stroke and vascular dementia, the underlying pathoge...
Gespeichert in:
Veröffentlicht in: | Lancet neurology 2019-07, Vol.18 (7), p.684-696 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 696 |
---|---|
container_issue | 7 |
container_start_page | 684 |
container_title | Lancet neurology |
container_volume | 18 |
creator | Wardlaw, Joanna M Smith, Colin Dichgans, Martin |
description | Small vessel disease is a disorder of cerebral microvessels that causes white matter hyperintensities and several other common abnormalities (eg, recent small subcortical infarcts and lacunes) seen on brain imaging. Despite being a common cause of stroke and vascular dementia, the underlying pathogenesis is poorly understood. Research in humans has identified several manifestations of cerebral microvessel endothelial dysfunction including blood–brain barrier dysfunction, impaired vasodilation, vessel stiffening, dysfunctional blood flow and interstitial fluid drainage, white matter rarefaction, ischaemia, inflammation, myelin damage, and secondary neurodegeneration. These brain abnormalities are more dynamic and widespread than previously thought. Relationships between lesions and symptoms are highly variable but poorly understood. Major challenges are the determination of which vascular dysfunctions are most important in pathogenesis, which abnormalities are reversible, and why lesion progression and symptomatology are so variable. This knowledge will help to identify potential targets for intervention and improve risk prediction for individuals with small vessel disease. |
doi_str_mv | 10.1016/S1474-4422(19)30079-1 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2232075714</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1474442219300791</els_id><sourcerecordid>2232075714</sourcerecordid><originalsourceid>FETCH-LOGICAL-c492t-f3ce0f824d2da285d7d743d7f95fa321e26a56b0293023d97ce1f2f6a6eba4203</originalsourceid><addsrcrecordid>eNqFkMtKAzEUhoMotlYfQRlwUxejyUlmMulGpHiDgovqOqTJGUzJzNRJW_DtnV7swo2r83P4zoWPkEtGbxll-d2UCSlSIQCGTN1wSqVK2RHp79t5dnzIAD1yFuOcUmCiYKekxxlVkhdZn4ymlQkhWWOMGBLnI5qIo6RC-2lqH6uYmNolNvjaWxMSXy1CF5a-qeM5OSlNiHixrwPy8fT4Pn5JJ2_Pr-OHSWqFgmVacou0LEA4cAaKzEknBXeyVFlpODCE3GT5jILiFLhT0iIrocxNjjMjgPIBGe72Ltrma4VxqSsfLYZgamxWUQNwoDKTTHTo9R903qzauvtuQykmVCaKjsp2lG2bGFss9aL1lWm_NaN6I1dv5eqNOc2U3srVrJu72m9fzSp0h6lfmx1wvwOw07H22OpoPdYWnW_RLrVr_D8nfgA5fYeb</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2239149548</pqid></control><display><type>article</type><title>Small vessel disease: mechanisms and clinical implications</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Wardlaw, Joanna M ; Smith, Colin ; Dichgans, Martin</creator><creatorcontrib>Wardlaw, Joanna M ; Smith, Colin ; Dichgans, Martin</creatorcontrib><description>Small vessel disease is a disorder of cerebral microvessels that causes white matter hyperintensities and several other common abnormalities (eg, recent small subcortical infarcts and lacunes) seen on brain imaging. Despite being a common cause of stroke and vascular dementia, the underlying pathogenesis is poorly understood. Research in humans has identified several manifestations of cerebral microvessel endothelial dysfunction including blood–brain barrier dysfunction, impaired vasodilation, vessel stiffening, dysfunctional blood flow and interstitial fluid drainage, white matter rarefaction, ischaemia, inflammation, myelin damage, and secondary neurodegeneration. These brain abnormalities are more dynamic and widespread than previously thought. Relationships between lesions and symptoms are highly variable but poorly understood. Major challenges are the determination of which vascular dysfunctions are most important in pathogenesis, which abnormalities are reversible, and why lesion progression and symptomatology are so variable. This knowledge will help to identify potential targets for intervention and improve risk prediction for individuals with small vessel disease.</description><identifier>ISSN: 1474-4422</identifier><identifier>EISSN: 1474-4465</identifier><identifier>DOI: 10.1016/S1474-4422(19)30079-1</identifier><identifier>PMID: 31097385</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Alzheimer's disease ; Aquaporins ; Blood flow ; Brain - blood supply ; Brain - diagnostic imaging ; Brain - physiopathology ; Brain damage ; Cerebral Small Vessel Diseases - diagnostic imaging ; Cerebral Small Vessel Diseases - physiopathology ; Cerebrovascular Circulation - physiology ; Cognitive ability ; Dementia ; Dementia disorders ; Disease Progression ; Early intervention ; Endothelium ; Endothelium, Vascular - diagnostic imaging ; Endothelium, Vascular - physiopathology ; Fluid flow ; Fluids ; Humans ; Hypertension ; Ischemia ; Magnetic Resonance Imaging ; Myelin ; Neurodegeneration ; Neuroimaging ; Pathogenesis ; Pathology ; Stroke ; Substantia alba ; Vascular dementia ; Vasodilation</subject><ispartof>Lancet neurology, 2019-07, Vol.18 (7), p.684-696</ispartof><rights>2019 Elsevier Ltd</rights><rights>Copyright © 2019 Elsevier Ltd. All rights reserved.</rights><rights>2019. Elsevier Ltd</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c492t-f3ce0f824d2da285d7d743d7f95fa321e26a56b0293023d97ce1f2f6a6eba4203</citedby><cites>FETCH-LOGICAL-c492t-f3ce0f824d2da285d7d743d7f95fa321e26a56b0293023d97ce1f2f6a6eba4203</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1474442219300791$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31097385$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wardlaw, Joanna M</creatorcontrib><creatorcontrib>Smith, Colin</creatorcontrib><creatorcontrib>Dichgans, Martin</creatorcontrib><title>Small vessel disease: mechanisms and clinical implications</title><title>Lancet neurology</title><addtitle>Lancet Neurol</addtitle><description>Small vessel disease is a disorder of cerebral microvessels that causes white matter hyperintensities and several other common abnormalities (eg, recent small subcortical infarcts and lacunes) seen on brain imaging. Despite being a common cause of stroke and vascular dementia, the underlying pathogenesis is poorly understood. Research in humans has identified several manifestations of cerebral microvessel endothelial dysfunction including blood–brain barrier dysfunction, impaired vasodilation, vessel stiffening, dysfunctional blood flow and interstitial fluid drainage, white matter rarefaction, ischaemia, inflammation, myelin damage, and secondary neurodegeneration. These brain abnormalities are more dynamic and widespread than previously thought. Relationships between lesions and symptoms are highly variable but poorly understood. Major challenges are the determination of which vascular dysfunctions are most important in pathogenesis, which abnormalities are reversible, and why lesion progression and symptomatology are so variable. This knowledge will help to identify potential targets for intervention and improve risk prediction for individuals with small vessel disease.</description><subject>Alzheimer's disease</subject><subject>Aquaporins</subject><subject>Blood flow</subject><subject>Brain - blood supply</subject><subject>Brain - diagnostic imaging</subject><subject>Brain - physiopathology</subject><subject>Brain damage</subject><subject>Cerebral Small Vessel Diseases - diagnostic imaging</subject><subject>Cerebral Small Vessel Diseases - physiopathology</subject><subject>Cerebrovascular Circulation - physiology</subject><subject>Cognitive ability</subject><subject>Dementia</subject><subject>Dementia disorders</subject><subject>Disease Progression</subject><subject>Early intervention</subject><subject>Endothelium</subject><subject>Endothelium, Vascular - diagnostic imaging</subject><subject>Endothelium, Vascular - physiopathology</subject><subject>Fluid flow</subject><subject>Fluids</subject><subject>Humans</subject><subject>Hypertension</subject><subject>Ischemia</subject><subject>Magnetic Resonance Imaging</subject><subject>Myelin</subject><subject>Neurodegeneration</subject><subject>Neuroimaging</subject><subject>Pathogenesis</subject><subject>Pathology</subject><subject>Stroke</subject><subject>Substantia alba</subject><subject>Vascular dementia</subject><subject>Vasodilation</subject><issn>1474-4422</issn><issn>1474-4465</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNqFkMtKAzEUhoMotlYfQRlwUxejyUlmMulGpHiDgovqOqTJGUzJzNRJW_DtnV7swo2r83P4zoWPkEtGbxll-d2UCSlSIQCGTN1wSqVK2RHp79t5dnzIAD1yFuOcUmCiYKekxxlVkhdZn4ymlQkhWWOMGBLnI5qIo6RC-2lqH6uYmNolNvjaWxMSXy1CF5a-qeM5OSlNiHixrwPy8fT4Pn5JJ2_Pr-OHSWqFgmVacou0LEA4cAaKzEknBXeyVFlpODCE3GT5jILiFLhT0iIrocxNjjMjgPIBGe72Ltrma4VxqSsfLYZgamxWUQNwoDKTTHTo9R903qzauvtuQykmVCaKjsp2lG2bGFss9aL1lWm_NaN6I1dv5eqNOc2U3srVrJu72m9fzSp0h6lfmx1wvwOw07H22OpoPdYWnW_RLrVr_D8nfgA5fYeb</recordid><startdate>201907</startdate><enddate>201907</enddate><creator>Wardlaw, Joanna M</creator><creator>Smith, Colin</creator><creator>Dichgans, Martin</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0TZ</scope><scope>3V.</scope><scope>7RV</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8AO</scope><scope>8C2</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>201907</creationdate><title>Small vessel disease: mechanisms and clinical implications</title><author>Wardlaw, Joanna M ; Smith, Colin ; Dichgans, Martin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c492t-f3ce0f824d2da285d7d743d7f95fa321e26a56b0293023d97ce1f2f6a6eba4203</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Alzheimer's disease</topic><topic>Aquaporins</topic><topic>Blood flow</topic><topic>Brain - blood supply</topic><topic>Brain - diagnostic imaging</topic><topic>Brain - physiopathology</topic><topic>Brain damage</topic><topic>Cerebral Small Vessel Diseases - diagnostic imaging</topic><topic>Cerebral Small Vessel Diseases - physiopathology</topic><topic>Cerebrovascular Circulation - physiology</topic><topic>Cognitive ability</topic><topic>Dementia</topic><topic>Dementia disorders</topic><topic>Disease Progression</topic><topic>Early intervention</topic><topic>Endothelium</topic><topic>Endothelium, Vascular - diagnostic imaging</topic><topic>Endothelium, Vascular - physiopathology</topic><topic>Fluid flow</topic><topic>Fluids</topic><topic>Humans</topic><topic>Hypertension</topic><topic>Ischemia</topic><topic>Magnetic Resonance Imaging</topic><topic>Myelin</topic><topic>Neurodegeneration</topic><topic>Neuroimaging</topic><topic>Pathogenesis</topic><topic>Pathology</topic><topic>Stroke</topic><topic>Substantia alba</topic><topic>Vascular dementia</topic><topic>Vasodilation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wardlaw, Joanna M</creatorcontrib><creatorcontrib>Smith, Colin</creatorcontrib><creatorcontrib>Dichgans, Martin</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Pharma and Biotech Premium PRO</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Nursing and Allied Health Journals</collection><collection>Neurosciences Abstracts</collection><collection>ProQuest Health and Medical</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>ProQuest Pharma Collection</collection><collection>Lancet Titles</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Psychology</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Lancet neurology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wardlaw, Joanna M</au><au>Smith, Colin</au><au>Dichgans, Martin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Small vessel disease: mechanisms and clinical implications</atitle><jtitle>Lancet neurology</jtitle><addtitle>Lancet Neurol</addtitle><date>2019-07</date><risdate>2019</risdate><volume>18</volume><issue>7</issue><spage>684</spage><epage>696</epage><pages>684-696</pages><issn>1474-4422</issn><eissn>1474-4465</eissn><abstract>Small vessel disease is a disorder of cerebral microvessels that causes white matter hyperintensities and several other common abnormalities (eg, recent small subcortical infarcts and lacunes) seen on brain imaging. Despite being a common cause of stroke and vascular dementia, the underlying pathogenesis is poorly understood. Research in humans has identified several manifestations of cerebral microvessel endothelial dysfunction including blood–brain barrier dysfunction, impaired vasodilation, vessel stiffening, dysfunctional blood flow and interstitial fluid drainage, white matter rarefaction, ischaemia, inflammation, myelin damage, and secondary neurodegeneration. These brain abnormalities are more dynamic and widespread than previously thought. Relationships between lesions and symptoms are highly variable but poorly understood. Major challenges are the determination of which vascular dysfunctions are most important in pathogenesis, which abnormalities are reversible, and why lesion progression and symptomatology are so variable. This knowledge will help to identify potential targets for intervention and improve risk prediction for individuals with small vessel disease.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>31097385</pmid><doi>10.1016/S1474-4422(19)30079-1</doi><tpages>13</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1474-4422 |
ispartof | Lancet neurology, 2019-07, Vol.18 (7), p.684-696 |
issn | 1474-4422 1474-4465 |
language | eng |
recordid | cdi_proquest_miscellaneous_2232075714 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Alzheimer's disease Aquaporins Blood flow Brain - blood supply Brain - diagnostic imaging Brain - physiopathology Brain damage Cerebral Small Vessel Diseases - diagnostic imaging Cerebral Small Vessel Diseases - physiopathology Cerebrovascular Circulation - physiology Cognitive ability Dementia Dementia disorders Disease Progression Early intervention Endothelium Endothelium, Vascular - diagnostic imaging Endothelium, Vascular - physiopathology Fluid flow Fluids Humans Hypertension Ischemia Magnetic Resonance Imaging Myelin Neurodegeneration Neuroimaging Pathogenesis Pathology Stroke Substantia alba Vascular dementia Vasodilation |
title | Small vessel disease: mechanisms and clinical implications |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T22%3A01%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Small%20vessel%20disease:%20mechanisms%20and%20clinical%20implications&rft.jtitle=Lancet%20neurology&rft.au=Wardlaw,%20Joanna%20M&rft.date=2019-07&rft.volume=18&rft.issue=7&rft.spage=684&rft.epage=696&rft.pages=684-696&rft.issn=1474-4422&rft.eissn=1474-4465&rft_id=info:doi/10.1016/S1474-4422(19)30079-1&rft_dat=%3Cproquest_cross%3E2232075714%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2239149548&rft_id=info:pmid/31097385&rft_els_id=S1474442219300791&rfr_iscdi=true |